FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/076049 [Registered on: 29/10/2024] Trial Registered Prospectively
Last Modified On: 27/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   To study relationship of serum LDH levels with mother and baby outcome in preeclampsia eclampsia patients 
Scientific Title of Study   A Study of relationship of serum lactate dehydrogenase levels with maternal and perinatal outcome in preeclampsia eclampsia  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Muskan 
Designation  Junior resident 
Affiliation  Guru Gobind Singh medical college and hospital Faridkot, punjab, india 
Address  Department of Obstetrics and Gynaecology Guru Gobind Singh Medical College, Faridkot, Punjab 151203 India

Faridkot
PUNJAB
151203
India 
Phone  9416153126  
Fax    
Email  Muskangarg858@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Seema Grover 
Designation  Professor and Head of department  
Affiliation  Guru Gobind Singh Medical College and Hospital Faridkot 
Address  Department of Obstetrics and Gynaecology Guru Gobind Singh Medical College, Faridkot, Punjab

Faridkot
PUNJAB
151203
India 
Phone  9417974348  
Fax    
Email  Groverseema@ggsmch.org  
 
Details of Contact Person
Public Query
 
Name  Seema Grover 
Designation  Professor and Head of department  
Affiliation  Guru Gobind Singh Medical College and Hospital Faridkot 
Address  Department of Obstetrics and Gynaecology Guru Gobind Singh Medical College, Faridkot, Punjab

Faridkot
PUNJAB
151203
India 
Phone  9417974348  
Fax    
Email  Groverseema@ggsmch.org  
 
Source of Monetary or Material Support  
Guru Gobind Singh Medical college Hospital, faridkot, Punjab , India Pincode- 151203 
 
Primary Sponsor  
Name  Guru Gobind Singh Medical College Hospital  
Address  Department of Obstetrics and Gynaecology, Guru Gobind Singh Medical College Hospital, Faridkot , Punjab, India Pincode- 151203 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Muskan  Guru Gobind Singh Medical College Hospital   Department of Obstetrics and Gynaecology, Guru Gobind Singh Medical College Hospital
Faridkot
PUNJAB 
9416153126

Muskangarg858@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Guru Gobind Singh Medical College   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O140||Mild to moderate pre-eclampsia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  30.00 Year(s)
Gender  Female 
Details  Antenatal preeclamptic and eclamptic women with singleton pregnancy and gestational age more than 28weeks 
 
ExclusionCriteria 
Details  Antenatal women with pre pregnancy hypertension and taking hepatotoxic drugs
Antenatal women with hemolytic anemia, liver disease, malignancy and coronary artery disease  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To establish a relationship of serum lactate dehydogenase levels with maternal and perinatal outcome in patients of peeclampsia eclampsia  outcome will be assessed at the end of one and half year of study 
 
Secondary Outcome  
Outcome  TimePoints 
To establish a relationship of serum lactate dehydrogenase levels with severity of disease in patients of preeclampsia eclampsia  outcome will be assessed at the end of one and half year of study 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Preeclampsia is one of the commonest and most dreaded compilcations of pregnancy. It is third most common cause of maternal mortality. LDH is an intracellular cytoplasmic enzyme and levels of LDH increase in preeclampsia due to cellular death and hemolysis. So, it is a useful biochemical marker to evaluate severity of preeclampsia . The analysis of LDH may enrich the ability to predict and prevent preeclampsia in near future. This can further help in making decision regarding the management strategies to improve maternal and fetal outcome in preeclampsia.
Aims and objectives : To measure serum LDH levels in patients of preeclampsia and to establish a relationship of serum LDH with fetomaternal outcome and severity of disease.

A prospective study will be conducted in GGS medical college and hospital , faridkot on 90 preeclamptic and eclamptic antenatal women with gestational age 28 weeks onwards with singleton pregnancy who will be admitted and delivered in our institute. 

Detailed history of patients, symptoms and complications of preeclampsia will be analyzed. Serum LDH levels will be estimated. All maternal complications, fetal outcome, gestational age at birth, APGAR score, birth weight and requirement of NICU admission will be analysed.
 
Close